Metraipolis › archive › dc_7c1db784c49d

Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post-Radiofrequency… — Europe PMC PMID:41026099

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41026099
DOI
10.1002/advs.202509309
License (as archived)
solo-consultazione
Archived
2026-11-09T15:19:19.446Z
SHA-256 of the archived text
b325995f2d232a687d5d4074cef444d1ed7beb29e7e264d72e16d97a73e43f98
Stable URL of this page
https://metraipolis.com/documento/dc_7c1db784c49d

How to cite

Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post-Radiofrequency… — Europe PMC PMID:41026099 — Europe PMC (en), https://europepmc.org/article/MED/41026099 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c1db784c49d (Metraipolis archive dc_7c1db784c49d, sha256 b325995f2d232a687d5d4074cef444d1ed7beb29e7e264d72e16d97a73e43f98)
BibTeX
@misc{dc7c1db784c49d,
  title = {Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post-Radiofrequency… — Europe PMC PMID:41026099},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41026099},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c1db784c49d; sha256 b325995f2d232a687d5d4074cef444d1ed7beb29e7e264d72e16d97a73e43f98},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41026099. Agents can read the archived copy with the MCP tool read_document.